arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide and substance p

arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide has been researched along with substance p in 1 studies

Compound Research Comparison

Studies (arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide)	Trials (arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide)	Recent Studies (post-2010) (arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide)	Studies (substance p)	Trials (substance p)	Recent Studies (post-2010) (substance p)
13	1	1	17,289	277	2,010

Protein Interaction Comparison

Protein	Taxonomy	substance p (IC50)
Substance-P receptor	Rattus norvegicus (Norway rat)	0.0005
Substance-K receptor	Rattus norvegicus (Norway rat)	0.2
Substance-K receptor	Homo sapiens (human)	0.2455
Substance-P receptor	Homo sapiens (human)	0.0011
Neuromedin-K receptor	Homo sapiens (human)	0.125
Substance-K receptor	Mesocricetus auratus (golden hamster)	0.148

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Byrne, B; Clive, S; Jodrell, DI; MacLellan, A; Robson, L; Smyth, JF; Webb, DJ; Young, A	1

Trials

1 trial(s) available for arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide and substance p

Article	Year
Forearm blood flow and local responses to peptide vasodilators: a novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonist. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:10 Topics: Adult; Aged; Antineoplastic Agents; Brachial Artery; Bradykinin; Dose-Response Relationship, Drug; Female; Flushing; Forearm; Humans; Infusion Pumps; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Neuropeptides; Oligopeptides; Regional Blood Flow; Substance P; Treatment Outcome; Vasodilator Agents	2001

Article

Year

Forearm blood flow and local responses to peptide vasodilators: a novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonist.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:10

Topics: Adult; Aged; Antineoplastic Agents; Brachial Artery; Bradykinin; Dose-Response Relationship, Drug; Female; Flushing; Forearm; Humans; Infusion Pumps; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Neuropeptides; Oligopeptides; Regional Blood Flow; Substance P; Treatment Outcome; Vasodilator Agents

2001